Benjamin Looker, General Counsel at Esperion Therapeutics, Inc. (ESPR), sold 6,422 shares at $1.15 ($7K) on 2025-06-17, disclosed to the SEC on 2025-06-18.
Open-market sale of $7k ESPR by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ESPR | SELL | 2026-01-21 | $5K | — | Filing → |
| ESPR | SELL | 2025-12-18 | $24K | — | Filing → |
| ESPR | SELL | 2025-10-20 | $3K | — | Filing → |